IP Library Granted Patent US 8,460,684
Granted Patent B2
US 8,460,684 · App. 11/084,068 · Granted Jun 11, 2013

Nuclease inhibitors and methods for their use

Inventors: Ronald T. Raines (Madison, WI); Bryan D. Smith (Madison, WI); Matthew B. Soellner (Madison, WI); David M. Lynn (Middleton, WI)
Assignee: Wisconsin Alumni Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,460,684
App. No.
11/084,068
Granted
Jun 11, 2013
Kind
B2
Abstract

A class of anionic oligomers and polymers that function for inhibition of nucleases, particularly RNase. Specific inhibitors include mixtures of oligomers of vinyl sulfate. Methods for inhibition or inactivation of one or more nucleases in vitro which comprises the step of contacting the one or more nucleases in a biological medium with one or more of the anionic oligomeric or polymeric inhibitors of this invention. Kits for carrying out a biological procedure, biological reaction and/or a biological assay containing one or more inhibitors of this invention. The use of oligomers and/or polymers of this invention as additives in buffers or reagents. The inhibitors of the invention can also be attached to surfaces to provide for removal of nucleases from media, solutions or other liquids in contact with the solid.

Claims (36)

1. A method for inhibiting one or more nuclease in vitro which comprises the step of contacting the one or more nuclease with an inhibitory composition which comprises one or more of the oligomers, polymers or both of formula:

where X is —SO 3 , —OSO 3 —PO 3 H, or —OPO 3 H, or salts thereof, n is an integer representing the number of repeating monomer units and n is 8 to 19, wherein the one or more oligomers, polymers or both are covalently bound to a solid.

2. The method of claim 1 in a biological medium wherein the contacting step comprises the step of adding the inhibitory composition to the biological medium.

3. The method of claim 1 wherein X is —SO 3 − .

4. The method of claim 3 wherein n is 8 to 18.

5. The method of claim 3 wherein n is 9 to 17.

6. The method of claim 1 wherein X is —SO 3 − .

7. The method of claim 6 wherein n is 8 to 18.

8. The method of claim 6 wherein n is 9 to 17.

9. The method of claim 1 wherein the nuclease is an RNase.

10. The method of claim 1 which comprises the step of contacting the biological medium with a material of formula:

where X is —SO 3 , —OSO 3 —PO 3 H, or —OPO 3 H, or salts thereof, where n is 8 to 19, L is a linker or spacer group and S is a solid.

11. The method of claim 10 wherein X is —SO 3 − .

12. The method of claim 10 wherein the solid is silica gel.

13. The method of claim 10 wherein the solid is a glass surface.

14. The method of claim 10 wherein the linker is —(CH 2 )p-NH—CO—C(CH 3 )— where p is 1 or more.

15. The method of claim 14 wherein p is 3-10.

16. The method of claim 14 where p is greater than 10.

17. The method of claim 1 wherein the solid is silica gel particles, glass beads, glass surfaces, cross-linked polystyrene, cross-linked PEG, microspheres, plastic surfaces or plastic beads.

18. The method of claim 1 wherein the solid is the internal surface of a container in which a buffer or reagent is to be carried or stored or in which a procedure, purification, isolation, assay or reaction is to be carried out.

19. The method of claim 1 wherein the inhibitory composition is a mixture of one or more oligomers covalently bound to the solid.

20. The method of claim 10 wherein the solid is silica gel particles, glass beads, glass surfaces, cross-linked polystyrene, cross-linked PEG, microspheres, plastic surfaces or plastic beads.

21. The method of claim 10 wherein n is 8 to 18.

22. The method of claim 1 wherein n is 8 to 18.

23. The method of claim 10 wherein n is 9 to 17.

24. The method of claim 1 wherein the oligomer or polymer is covalently bonded to the solid by polymerization of monomers of the oligomer or polymer on the surface.

25. The method of claim 10 wherein the oligomer or polymer is covalently bonded to the solid by polymerization of monomers of the oligomer or polymer on linker L.

26. The method of claim 11 wherein n is 8 to 18.

27. The method of claim 10 wherein the nuclease is a RNase.

28. A method for inhibiting one or more nuclease in vitro which comprises the step of contacting the one or more nuclease with an inhibitory composition which comprises one or more of the oligomers, polymers or both of formula:

where X is —SO 3 , —OSO 3 —PO 3 H, or —OPO 3 H, or salts thereof, n is an integer representing the number of repeating monomer units and n is 8 to 19.

29. The method of claim 28 wherein n is 8 to 18.

30. The method of claim 28 wherein X is —SO 3 − .

31. The method of claim 30 wherein n is 8 to 18.

32. The method of claim 30 wherein n is 9-17.

33. The method of claim 1 where n is 9 to 17.

Assignments (3)
CONFIRMATORY LICENSE Recorded Mar 15, 2018
From: UNIVERSITY OF WISCONSIN-MADISON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045603/0528 →
CONFIRMATORY LICENSE Recorded Jun 10, 2009
From: UNIVERSITY OF WISCONSIN MADISON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022807/0446 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2005
From: RAINES, RONALD T.; SMITH, BRYAN D.; LYNN, DAVID M.; SOELLNER, MATTHEW B.
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 015994/0695 →
Continuity (3)
Provisional Application 60554793 · Mar 19, 2004
Provisional Application 60635379 · Dec 10, 2004
Related Publication 20050214839A1 · Sep 29, 2005